Condition
Abdominal Neoplasm|Colonic Neoplasm|Mesothelioma|Peritoneal Neoplasm
Estimated Enrollment: 188
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 000069|00-C-0069
Study First Received: February 3, 2000
Last Updated: October 19, 2015
Estimated Primary Completion Date: August 2009
Primary Outcome Measures:
Number of Participants With Disease-free Survival|Number of Participants With a Response|Number of Participants With Adverse Events|Percentage of Participants Who Had Paclitaxel and 5-fluorouracil (5-FU) Analysis Performed|Quality of Life Questionnaire Score|Signal Transduction Pathways in Tumor Tissue Versus Normal Tissue
Sponsors and Collaborators:
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Website Link: https://ClinicalTrials.gov/show/NCT00004547
